glp-1 substitute FDA approves Foundayo, an oral alternative to Wegovy and Ozempic Potential GLP-1 Alternative Promises Weight

Additional Information Good to Know Contains the goodness of antioxidants

Impact on cancer, mortality risks During mean follow-up of 3.9 years, investigators identified 2,501 new obesity-related cancers in the GLP-1 group and 2,671 in the DPP-4 group

M., Mellacheruvu, D

Oxalate homeostasis

1 The terminology of MAFLD was defined by evidence of hepatic steatosis based on histopathological examination, imaging, or blood biomarkers in association with one of three criteria, including obesity or overweight status, type 2 diabetes mellitus (T2DM) and evidence of metabolic dysregulation, with at least two metabolic risk factors, including high waist circumference, hypertension, hypertriglyceridemia, low high-density lipoprotein-cholesterolemia, prediabetes, insulin resistance, and high-sensitivity C-reactive protein level

Digestion 73 , 142150 (2006)